These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18990384)

  • 1. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
    Orvieto R; Homburg R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
    Chen W; Zhang Y; Dai Q
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
    Mitwally MF; Casper RF
    J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.
    Balen AH; Platteau P; Andersen AN; Devroey P; Sørensen P; Helmgaard L; Arce JC
    BJOG; 2006 Oct; 113(10):1195-202. PubMed ID: 16903840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
    Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization.
    Koundouros SN
    Fertil Steril; 2008 Sep; 90(3):569-75. PubMed ID: 17880950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome.
    van Wely M; Fauser BC; Laven JS; Eijkemans MJ; van der Veen F
    Fertil Steril; 2006 Dec; 86(6):1710-5. PubMed ID: 17022982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation induction in normogonadotropic anovulation (PCOS).
    van Santbrink EJ; Fauser BC
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):261-70. PubMed ID: 16772156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proper selection of patients for intermediate-dose pure follicle stimulating hormone.
    Kim JH; Richards CJ; Seibel MM
    J Reprod Med; 1994 Jan; 39(1):1-5. PubMed ID: 8169907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.
    Homburg R; Levy T; Ben-Rafael Z
    Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in induction of ovulation.
    Franks S; Gilling-Smith C
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):136-40. PubMed ID: 8193252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study.
    Hugues JN; Cédrin-Durnerin I; Howles CM; ; Amram M; Angelini A; Balen A; Barbereau D; Birkhauser M; Boujenah A; De Leo V; De Placido G; Dessole S; Favrin S; Ferrazi E; Gay C; Germond M; Hedon B; Hocke C; Jolly C; Lamarca-Roth E; Lanzone A; Marchand F; Marcolin G; Mascaretti G; Moreau L; Massobrio M; Nappi C; Pardi G; Pennehouat G; Porcu E; Seibert M; Selvaggi L; Thiers D; Venturini P
    Hum Reprod; 2006 Nov; 21(11):2817-22. PubMed ID: 16877376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome.
    Lan VT; Norman RJ; Nhu GH; Tuan PH; Tuong HM
    Reprod Biomed Online; 2009 Apr; 18(4):516-21. PubMed ID: 19400993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment.
    Fulghesu AM; Apa R; Belosi C; Ciampelli M; Selvaggi L; Cucinelli F; Caruso A; Mancuso S; Lanzone A
    Horm Res; 2001; 55(5):224-8. PubMed ID: 11740143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
    Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
    Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.